Through downstream effectors such as the Ras/Raf/MAPK and PI3K/Akt/mTOR signaling pathways, EGFR activation could induce tumor cell proliferation and survival (Fan and Weiss, 2012; Gao et al., 2013). This evidence concerns the gene EGFR and neoplasm.